Wechter Mary Ellen, Mohd Jasmine, Magrina Javier F, Cornella Jeffrey L, Magtibay Paul M, Wilson Jeffrey R, Kho Rosanne M
Department of Obstetrics and Gynecology, North Florida OBGYN, Division 1, Baptist Medical Center, Jacksonville, Florida.
Department of Minimally Invasive Surgery, KK Women's and Children's Hospital, Singapore.
J Minim Invasive Gynecol. 2014 Sep-Oct;21(5):844-50. doi: 10.1016/j.jmig.2014.03.016. Epub 2014 Mar 31.
To estimate the risk of postoperative complications in robotic-assisted gynecologic surgery according to case type.
Retrospective cohort study (Canadian Task Force classification II-2).
Mayo Clinic Arizona.
All 1155 patients who underwent robotic-assisted gynecologic surgery between March 2004 and December 2009 were included. Patients were primarily white (94.3%), with a mean (SD) age of 51.5 (15.4) years, and were overweight, with body mass index (BMI) of 27.2 (6.8).
Risk of complications, overall and according to Clavien-Dindo grade, and incidence of specific complications were analyzed. Robotic-assisted gynecologic surgical procedures were categorized postoperatively according to case type as benign simple (e.g., oophorectomy, simple hysterectomy) in 552 (47.8%) patients, benign complex (e.g., excision of invasive endometriosis) in 262 (22.7%), urogynecologic in 121 (10.5%), and oncologic in 220 (19.1%).
Intraoperative complications occurred in 3.2% of patients. Postoperative complications of any type occurred in 18.4% of patients. Conversion to laparotomy was necessary in 2.7%. Urologic complications were more common in urogynecologic cases (5.8%) as compared with benign simple (0.5%), benign complex (2.7%), and oncologic (3.2%). Bleeding complications were most common in oncologic cases (5%). Clavien-Dindo grade ≥ 3 complications occurred in 5.2% of patients overall, and were >3-fold likely to occur in benign complex, urogynecologic, and oncologic cases than in benign simple cases. When adjusted for age, BMI, estimated blood loss, operative time, length of stay, and previous pelvic surgery, complications were nearly twice as common for benign complex (odds ratio [OR] 1.7; 95% confidence interval [CI], 1.1-2.7), urogynecologic (OR 1.9; 95% CI, 1.0-3.4), and oncologic (OR 1.9; 95% CI, 1.1-3.1) cases as for benign simple cases, although weakly significant. Case type, BMI, estimated blood loss, and length of stay remained important factors in predicting postoperative complications.
The incidence of complications in robotic-assisted gynecologic surgery varies according to case type. Defining the role of patient and surgical variables such as case type in the occurrence of complications may help in identification of cases with increased risk, to improve patient counseling and surgical outcome.
根据病例类型评估机器人辅助妇科手术术后并发症的风险。
回顾性队列研究(加拿大工作组分类II-2)。
亚利桑那州梅奥诊所。
纳入2004年3月至2009年12月期间接受机器人辅助妇科手术的1155例患者。患者主要为白人(94.3%),平均(标准差)年龄51.5(15.4)岁,体重超重,体重指数(BMI)为27.2(6.8)。
分析总体并发症风险及根据Clavien-Dindo分级的并发症风险,以及特定并发症的发生率。机器人辅助妇科手术术后根据病例类型分为良性简单手术(如卵巢切除术、单纯子宫切除术)552例(47.8%)、良性复杂手术(如浸润性子宫内膜异位症切除术)262例(22.7%)、泌尿妇科手术121例(10.5%)和肿瘤手术220例(19.1%)。
3.2%的患者发生术中并发症。18.4%的患者发生任何类型的术后并发症。2.7%的患者需要转为开腹手术。泌尿妇科手术中泌尿系统并发症(5.8%)比良性简单手术(0.5%)、良性复杂手术(2.7%)和肿瘤手术(3.2%)更常见。出血并发症在肿瘤手术中最常见(5%)。总体上5.2%的患者发生Clavien-Dindo≥3级并发症,良性复杂手术、泌尿妇科手术和肿瘤手术发生此类并发症的可能性是良性简单手术的3倍以上。在对年龄、BMI、估计失血量、手术时间、住院时间和既往盆腔手术进行校正后,良性复杂手术(优势比[OR]1.7;95%置信区间[CI],1.1-2.7)、泌尿妇科手术(OR 1.9;95%CI,1.0-3.4)和肿瘤手术(OR 1.9;95%CI,1.1-3.1)发生并发症的几率几乎是良性简单手术的两倍,尽管差异无统计学意义。病例类型、BMI、估计失血量和住院时间仍是预测术后并发症的重要因素。
机器人辅助妇科手术并发症的发生率因病例类型而异。明确患者和手术变量如病例类型在并发症发生中的作用,可能有助于识别风险增加的病例,以改善患者咨询和手术效果。